A PHASE III, MULTICENTER, RANDOMIZED STUDY OF THE EFFICACY, SAFETY, AND PHARMACOKINETICS OF THE PORT DELIVERY SYSTEM WITH RANIBIZUMAB IN PATIENTS WITH DIABETIC RETINOPATHY (PAVILION)
Clinical Trial Grant
Administered By
Ophthalmology, Vitreoretinal Diseases & Surgery
Awarded By
Genentech, Inc.
Start Date
December 7, 2020
End Date
December 31, 2025
Administered By
Ophthalmology, Vitreoretinal Diseases & Surgery
Awarded By
Genentech, Inc.
Start Date
December 7, 2020
End Date
December 31, 2025